Please use this identifier to cite or link to this item:
Title: Mitochondrial targeted catalase suppresses invasive breast cancer in mice
Authors: Goh, Jorming 
Enns, Linda
Fatemie, Soroosh
Hopkins, Heather
Morton, John
Pettan-Brewer, Christina
Ladiges, Warren
Keywords: Science & Technology
Life Sciences & Biomedicine
Issue Date: 23-May-2011
Citation: Goh, Jorming, Enns, Linda, Fatemie, Soroosh, Hopkins, Heather, Morton, John, Pettan-Brewer, Christina, Ladiges, Warren (2011-05-23). Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC CANCER 11 (1). ScholarBank@NUS Repository.
Abstract: Background: Treatment of invasive breast cancer has an alarmingly high rate of failure because effective targets have not been identified. One potential target is mitochondrial generated reactive oxygen species (ROS) because ROS production has been associated with changes in substrate metabolism and lower concentration of anti-oxidant enzymes in tumor and stromal cells and increased metastatic potential.Methods: Transgenic mice expressing a human catalase gene (mCAT) were crossed with MMTV-PyMT transgenic mice that develop metastatic breast cancer. All mice (33 mCAT positive and 23 mCAT negative) were terminated at 110 days of age, when tumors were well advanced. Tumors were histologically assessed for invasiveness, proliferation and metastatic foci in the lungs. ROS levels and activation status of p38 MAPK were determined.Results: PyMT mice expressing mCAT had a 12.5 per cent incidence of high histological grade primary tumor invasiveness compared to a 62.5 per cent incidence in PyMT mice without mCAT. The histological grade correlated with incidence of metastasis with 56 per cent of PyMT mice positive for mCAT showing evidence of pulmonary metastasis compared to 85.4 per cent of PyMT mice negative for mCAT with pulmonary metastasis (p ≤ 0.05). PyMT tumor cells expressing mCAT had lower ROS levels and were more resistant to hydrogen peroxide-induced oxidative stress than wild type tumor cells, suggesting that mCAT has the potential of quenching intracellular ROS and subsequent invasive behavior. The metastatic tumor burden in PyMT mice expressing mCAT was 0.1 mm2/cm2 of lung tissue compared with 1.3 mm2/cm2 of lung tissue in PyMT mice expressing the wild type allele (p ≤ 0.01), indicating that mCAT could play a role in mitigating metastatic tumor progression at a distant organ site. Expression of mCAT in the lungs increased resistance to hydrogen peroxide-induced oxidative stress that was associated with decreased activation of p38MAPK suggesting ROS signaling is dependent on p38MAPK for at least some of its downstream effects.Conclusion: Targeting catalase within mitochondria of tumor cells and tumor stromal cells suppresses ROS-driven tumor progression and metastasis. Therefore, increasing the antioxidant capacity of the mitochondrial compartment could be a rational therapeutic approach for invasive breast cancer.Please see related commentary article: © 2011 Goh et al; licensee BioMed Central Ltd.
Source Title: BMC CANCER
ISSN: 1471-2407
DOI: 10.1186/1471-2407-11-191
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Mitochondrial targeted catalase suppresses invasive breast cancer in mice.pdf1.28 MBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.